Medicine Grand Rounds on Friday, April 6, 2018:
“The Many Faces of Myopathy”
Chester V. Oddis MD
Professor of Medicine
Associate Director, Rheumatology Fellowship Training Program
University of Pittsburgh School of Medicine
Director, Myositis Center
University of Pittsburgh Medical Center
8:00 a.m. – 9:00 a.m.
Auditorium E, Rubin Building, Dartmouth-Hitchcock Medical Center
Co-sponsored by the Section of Rheumatology and the Department of Medicine Geisel School of Medicine at Dartmouth
- Discuss the various cause of muscle weakness relevant to the internist
- Recognize drug-induced (statin-associated) myopathic syndromes
- Understand and recognize the systemic features of inflammatory myopathies beyond myositis
Dr. Oddis has been Professor of Medicine in the Division of Rheumatology and Clinical Immunology since 2001 and Director of the Myositis Center since 2010. He has devoted most of his career to the investigation and treatment of inflammatory myopathy. He has conducted research on the epidemiology, clinical features, autoantibody associations, pathogenesis, and treatment of myositis. He has authored or co-authored over 170 peer-reviewed and invited publications, most of them related to inflammatory muscle disease and its co-morbidities. As Director of the Myositis Center at the University of Pittsburgh, he supervises and manages a clinically- and serologically-defined, longitudinal myositis registry of over 1,000 patients with adult polymyositis, adult dermatomyositis, and overlap myositis disorders. He served as principal investigator of an NIH-funded multicenter clinical trial of rituximab in the treatment of myositis, the largest trial ever completed for this disease. He has contributed significantly to characterizing the pulmonary manifestations of inflammatory myopathy, particularly interstitial lung disease, and he has served on a number of panels to for developing clinical trial guidelines for both myositis and autoimmune interstitial lung disease. He and his colleagues developed the web-based Rheumatic Disease Data Management System, which enables myositis investigators to link disease activity and damage measures with clinical, laboratory, serologic and experimental data over time. His current research is funded by NIH, private sources, and industry. He is currently participating in a large number of national and international collaborations, including several multicenter clinical trials for the therapy of myositis.
If you are unable to attend and wish to view Grand Rounds live on your computer please use this link: http://med.dartmouth-hitchcock.org/education/dept_medicine_grand_rounds_live.html
Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education programs for physicians.
Dartmouth-Hitchcock designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
